Edwards Lifesciences Corp (EW) Com Stk USD1

Sell:$76.02Buy:$76.03$0.55 (0.73%)

Prices delayed by at least 15 minutes
Sell:$76.02
Buy:$76.03
Change:$0.55 (0.73%)
Deal now
Prices delayed by at least 15 minutes
Sell:$76.02
Buy:$76.03
Change:$0.55 (0.73%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

Key people

Bernard J. Zovighian
Chief Executive Officer, Director
Scott B. Ullem
Chief Financial Officer, Corporate Vice President
Wayne T. Markowitz
Senior Vice President - Surgical Structural Heart, General Manager
Donald E. Bobo
Corporate Vice President - Strategy and Corporate Development
Annette Maria Bruls
Corporate Vice President - EMEACLA (Europe, Middle East, Africa, Canada and Latin America)
Daveen Chopra
Corporate Vice President - Transcatheter Mitral and Tricuspid Therapies
Daniel J. Lippis
Corporate Vice President - JAPAC (Japan, Greater China and Asia Pacific)
Larry L. Wood
Corporate Vice President, Group President - Transcatheter Aortic Valve Replacement (TAVR) and Surgical Structural Heart
Nicholas J. Valeriani
Independent Chairman of the Board
Leslie C. Davis
Independent Director
David T. Feinberg
Independent Director
Kieran T. Gallahue
Independent Director
Leslie S. Heisz
Independent Director
Click to see more

Key facts

  • EPIC
    EW
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US28176E1082
  • Market cap
    $41.42bn
  • Employees
    15,800
  • Shares in issue
    654.10m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.